IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Overview of attention for article published in Blood Cancer Discovery, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 222)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 12 news stories from 12 outlets.

Précis Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity…

By Elana Gotkine HealthDay Reporter THURSDAY, Oct. 5, 2023 -- Many patients with multiple myeloma treated with anti-B cell…

THURSDAY, Oct. 5, 2023 (HealthDay News) -- Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA…

THURSDAY, Oct. 5, 2023 (HealthDay News) -- Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 8 additional news stories.